Clinical Trial Update: Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

A Phase IV multicenter trial of olaparib in Indian patients with ovarian cancer and metastatic breast cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer, Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2025-03-10